AU2001292301A1 - Novel drugs for liver diseases - Google Patents

Novel drugs for liver diseases

Info

Publication number
AU2001292301A1
AU2001292301A1 AU2001292301A AU9230101A AU2001292301A1 AU 2001292301 A1 AU2001292301 A1 AU 2001292301A1 AU 2001292301 A AU2001292301 A AU 2001292301A AU 9230101 A AU9230101 A AU 9230101A AU 2001292301 A1 AU2001292301 A1 AU 2001292301A1
Authority
AU
Australia
Prior art keywords
liver diseases
novel drugs
drugs
novel
liver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292301A
Inventor
Kensuke Egashira
Masamichi Koyanagi
Makoto Nakamuta
Ken-Ichi Nishida
Akira Takeshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of AU2001292301A1 publication Critical patent/AU2001292301A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU2001292301A 2000-10-11 2001-09-28 Novel drugs for liver diseases Abandoned AU2001292301A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000310604 2000-10-11
JP2000-310604 2000-10-11
PCT/JP2001/008552 WO2002030464A1 (en) 2000-10-11 2001-09-28 Novel drugs for liver diseases

Publications (1)

Publication Number Publication Date
AU2001292301A1 true AU2001292301A1 (en) 2002-04-22

Family

ID=18790533

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292301A Abandoned AU2001292301A1 (en) 2000-10-11 2001-09-28 Novel drugs for liver diseases

Country Status (8)

Country Link
US (1) US7335647B2 (en)
EP (1) EP1325751A4 (en)
JP (1) JPWO2002030464A1 (en)
CN (1) CN1469756A (en)
AU (1) AU2001292301A1 (en)
CA (1) CA2425765A1 (en)
NO (1) NO20031650L (en)
WO (1) WO2002030464A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
ATE442862T2 (en) 2000-10-12 2009-10-15 Genentech Inc LOW VISCOSE CONCENTRATED PROTEIN FORMULATIONS
WO2003037376A1 (en) * 2001-11-02 2003-05-08 Kensuke Egashira Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
US7476381B2 (en) * 2002-12-23 2009-01-13 Laboratoires Serono Sa Methods of reducing serum alanine transferase levels in a subject with hepatitis
AU2004229335C1 (en) 2003-04-04 2010-06-17 Genentech, Inc. High concentration antibody and protein formulations
US20100074886A1 (en) * 2006-10-05 2010-03-25 Anuk Das Ccr2 antagonists for treatment of fibrosis
SG175621A1 (en) * 2006-10-12 2011-11-28 Novartis Ag Use of modified cyclosporins
MX2011009306A (en) 2009-03-06 2011-10-13 Genentech Inc Antibody formulation.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399346A (en) * 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US5739103A (en) * 1993-11-12 1998-04-14 Dana-Farber Cancer Institute Chemokine N-terminal deletion mutations
US5459128A (en) 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
JP3720861B2 (en) 1994-10-21 2005-11-30 帝人株式会社 Prostaglandins and process for producing the same
GB9501683D0 (en) 1995-01-27 1995-03-15 Glaxo Group Ltd Substances and their uses
JPH0967399A (en) 1995-08-30 1997-03-11 Mitsui Toatsu Chem Inc Anti-mcp-1 human monoclonal antibody
JP2000516611A (en) * 1996-08-14 2000-12-12 ワーナー―ランバート・コンパニー 2-Phenylbenzimidazole derivatives as MCP-1 antagonists
GB9716656D0 (en) * 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
JPH1160502A (en) 1997-08-12 1999-03-02 Teijin Ltd Therapeutic prophylactic agent for cerebral infarction
JP2000239182A (en) 1999-02-19 2000-09-05 Mitsubishi Chemicals Corp Antiinflammatory agent

Also Published As

Publication number Publication date
WO2002030464A1 (en) 2002-04-18
CN1469756A (en) 2004-01-21
EP1325751A1 (en) 2003-07-09
JPWO2002030464A1 (en) 2004-02-19
NO20031650L (en) 2003-06-05
NO20031650D0 (en) 2003-04-10
US7335647B2 (en) 2008-02-26
CA2425765A1 (en) 2003-04-11
EP1325751A4 (en) 2005-05-04
US20050053603A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
AU1071301A (en) Pharmaceutical compounds
AU2001269529A1 (en) Medicine comprising dicyanopyridine derivative
AU781269C (en) Pharmaceutical compositions
AU2002222853A1 (en) Therapeutic compounds
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2270101A (en) Pharmaceutical kit
AU2002302147A1 (en) Pharmaceutical composition
AU6715600A (en) Pharmaceutical formulations
AU2002232468A1 (en) Pharmaceutical heterocyclic compounds
AU2001273919A1 (en) Pharmaceutical compositions
AU2002221099A1 (en) Combination drugs
AU2001292301A1 (en) Novel drugs for liver diseases
AU4977300A (en) Pharmaceutical formulations
AU5722900A (en) Pharmaceutical compounds
AU1385801A (en) Pharmaceutical formulations
AU4085201A (en) Pharmaceutical composition
AU2002333276A1 (en) Drugs for vasculopaties
AU2001292578A1 (en) Pharmaceutical compounds
AU4914400A (en) Novel pharmaceutical composition
AU3586401A (en) Pharmaceutical composition
AU2001278705A1 (en) Pharmaceutical composition
AU2001292001A1 (en) Pharmaceutical oxan preparation
AU2002342940A1 (en) New pharmaceutical compounds
AUPR529701A0 (en) Pharmaceutical composition